Related Experiment Video
Updated: Sep 27, 2025
08:26
Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
Published on: October 19, 2021
5.8K
Optimization of a locomotion-based zebrafish seizure model
Philip Anthony Gilbert Shaw1, Sujogya Kumar Panda2, Alexandru Stanca1
1Department of Biology, KU Leuven, Naamsestraat 59, 3000 Leuven, Belgium.
Journal of Neuroscience Methods
|April 14, 2022
Summary
Optimized zebrafish locomotor assays improve early drug discovery for antiseizure compounds. Standardized conditions using pentylenetetrazol and valproate provide reliable, non-toxic screening for novel anticonvulsants.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Discovery
Background:
- Locomotor assays in zebrafish are crucial for early drug discovery of antiseizure compounds.
- Discrepancies in published studies hinder reliable results for antiseizure medications.
Purpose of the Study:
- Optimize a locomotor-based seizure assay in zebrafish for screening antiseizure compounds.
- Establish reliable experimental parameters for PTZ-induced seizures and VPA as a control.
Main Methods:
- Utilized pentylenetetrazol (PTZ) as a proconvulsant in zebrafish larvae.
- Optimized exposure time and valproate (VPA) concentration for reliable control.
- Employed an infrared-beam motility assay to quantify locomotion.
Main Results:
- Three zebrafish larvae per well showed less motility variability compared to one.
- 10 mM PTZ significantly increased locomotion without toxicity.
- 3 mM VPA demonstrated the strongest reduction in PTZ-induced movement without toxicity.
- 18-hour VPA exposure was more effective than 2-hour exposure.
Conclusions:
- Standardized conditions for larval zebrafish PTZ-induced seizure model are recommended.
- Avoid toxic PTZ concentrations; use 10 mM PTZ for 1 hour with 3 larvae/well.
- Recommend 3 mM VPA for 18 hours as a positive control for anticonvulsant activity.
